High-dose compared with intermediate-dose methotrexate in children with a first relapse of acute lymphoblastic leukemia.
about
ALK-positive diffuse large B-cell lymphoma: report of four cases and review of the literatureEffect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trialMethotrexate-induced side effects are not due to differences in pharmacokinetics in children with Down syndrome and acute lymphoblastic leukemia.Lymphoblastic lymphoma in childhood and adolescence.Psychosexual development and satisfaction in long-term survivors of childhood cancer: Neurotoxic treatment intensity as a risk indicator.Treatment of childhood acute lymphoblastic leukemia in central America: a lower-middle income countries experience.Novel therapy for childhood acute lymphoblastic leukemia.High-dose methotrexate therapy significantly improved survival of adult acute lymphoblastic leukemia: A phase III study by JALSG.Determination of Methotrexate, 7-Hydroxymethotrexate, and 2,4-Diamino-N10-methylpteroic Acid by LC-MS/MS in Plasma and Cerebrospinal Fluid and Application in a Pharmacokinetic Analysis of High-Dose Methotrexate.Re: High-dose compared with intermediate-dose methotrexate in children with a first relapse of acute lymphatic leukemia.Effect of high-dose methotrexate chemotherapy on intestinal Bifidobacteria, Lactobacillus and Escherichia coli in children with acute lymphoblastic leukemia.Outcomes of treatment for relapsed acute lymphoblastic leukaemia in children with Down syndrome.Autologous purified peripheral blood stem cell transplantation compare to chemotherapy in childhood acute lymphoblastic leukemia after low-risk relapse.
P2860
Q21198873-EF166320-C8B2-47CA-A0E6-446F09B394EEQ24621523-1ED77EBD-7CED-424E-860B-62673F0B6840Q33952766-FF851E3E-7E74-40E0-816D-D3F3C671A262Q38102065-874D589C-9CAB-492D-8F41-0AF0C338DDD5Q38976932-0D5E27E7-4CBB-4767-A5C3-C0CC21B058B5Q39199790-3B6635D4-D727-45BA-AF99-D6778E3A019AQ39368957-EA6CE07B-A1F9-439D-BE5E-5734774DF2C6Q40044204-6D21AD68-47A1-447B-B2CB-2CE526EC5461Q41444080-108FAFF2-336C-41ED-B722-0055CB45937CQ42403051-00BB82DA-5688-47FD-B87F-93E422DE6C3BQ44485421-1C84EDB6-B0FE-4A00-AE6F-468E66D440C9Q45723589-65B77B7A-6B40-49C0-96AF-5D919128BCA0Q52895510-4751FDBD-1A3C-4F03-B553-13E403D7A141
P2860
High-dose compared with intermediate-dose methotrexate in children with a first relapse of acute lymphoblastic leukemia.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
High-dose compared with interm ...... acute lymphoblastic leukemia.
@en
High-dose compared with interm ...... acute lymphoblastic leukemia.
@nl
type
label
High-dose compared with interm ...... acute lymphoblastic leukemia.
@en
High-dose compared with interm ...... acute lymphoblastic leukemia.
@nl
prefLabel
High-dose compared with interm ...... acute lymphoblastic leukemia.
@en
High-dose compared with interm ...... acute lymphoblastic leukemia.
@nl
P2093
P50
P1433
P1476
High-dose compared with interm ...... acute lymphoblastic leukemia.
@en
P2093
ALL-REZ BFM Study Group
Alfred Reiter
Christoph Bührer
Georg Mann
Gritta Janka-Schaub
Günter Henze
Jörg Ritter
Reinhard Hartmann
Richard Ratei
Rüdiger Fengler
P304
P356
10.1182/BLOOD-2007-07-102525
P407
P577
2007-12-18T00:00:00Z